Increased Parathyroid Hormone Concentrations in Dogs with Hyperadrenocorticism
World Small Animal Veterinary Association World Congress Proceedings, 2003
I.K. Ramsey; A. Tebb; Y.McGrotty; E. Harris; H. Evans; M.E Herrtage
University of Glasgow, Department of Veterinary Clinical Studies
Glasgow, UK

Objectives

To assess the effects of hyperadrenocorticism on parathyroid hormone (PTH) secretion in the dog.

Materials & Methods

PTH was measured in 68 dogs with confirmed hyperadrenocorticism that did not have azotaemia. Routine biochemical screens were obtained from all dogs and ionised calcium was measured in 28 of the dogs. The results obtained were compared to an age and weight matched group of twenty hospital patients that did not have hyperadrenocorticism or azotaemia.

Results

It was found that there was significant difference between the PTH, phosphate and albumin concentrations between the two groups. Calcium concentrations were not significantly different. A large proportion (92%) of the dogs with hyperadrenocorticism had PTH concentrations that were greater than the established laboratory reference range (10-60 pg/ml). Furthermore 23 dogs had PTH concentrations that were greater than 3 times the upper limit of the reference range (180 pg/ml). There were significant but weak correlations between the PTH and basal cortisol concentrations and the phosphate and post-ACTH cortisol concentrations.

Conclusion

Increased PTH is likely to be a factor in the pathogenesis of those clinical signs of hyperadrenocorticism that are associated with defects in calcium homeostasis (e.g., calcinosis cutis).

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

I. K. Ramsey
University of Glasgow, Department of Veterinary Clinical Studies
Glasgow, UK


MAIN : Oral Presentations : Increased Parathyroid Hormone
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27